Redhill Biopharma (RDHL) vs China SXT Pharmaceuticals (SXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($4.2 million vs $3.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | RDHL | SXTC |
|---|---|---|
| Share price | $0.474 | $2.83 |
| Market cap | $4.21M | $3.74M |
| 1-day change | -2.07% | +126.40% |
| Forward P/E | 15.80 | — |
| EPS (TTM) | $0.00 | $-1,680.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.14 | $83,760.00 |
| 52-week low | $0.465 | $1.18 |
| Distance from 52-week high | -77.85% | -100.00% |
| Average volume | 1.81M | 3.73M |
| Shares outstanding | 8.89M | 1.32M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
RDHL vs SXTC FAQ
Which is bigger, Redhill Biopharma or China SXT Pharmaceuticals?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $4.21M compared with $3.74M for China SXT Pharmaceuticals (SXTC).
Are Redhill Biopharma and China SXT Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.